News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Azenta Life Sciences and Form Bio Partner to Support AAV Gene Therapy Development
Wednesday, May 14, 2025Azenta Life Sciences has announced a strategic partnership between its GENEWIZ division and Form Bio an artificial intelligence AI life sciences technology company
Beam Therapeutics Receives U.S. FDA RMAT Designation for BEAM-302 to Treat Alpha-1 Antitrypsin Deficiency
Tuesday, May 13, 2025Beam Therapeutics Inc a biotechnology company focused on precision genetic medicine through base editing has received Regenerative Medicine Advanced Therapy RMAT designation from the United States Food and Drug Administration FDA for BEAM This invest...
ViVerita Therapeutics Collaborates with Boehringer Ingelheim to Advance Cancer Target Discovery
Thursday, May 08, 2025ViVerita Therapeutics a USbased company specialising in precision oncology has entered into a research collaboration with Boehringer Ingelheim to accelerate the identification and validation of new therapeutic targets for cancer treatment
Viralgen Partners with Trogenix to Advance AAV Gene Therapy for Glioblastoma
Wednesday, May 07, 2025Viralgen a leading contract development and manufacturing organisation CDMO specialising in recombinant adenoassociated virus rAAV gene therapies has entered into a strategic partnership with Trogenix a biotech company focused on developing innovativ...
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug to Treat Tumour-Induced Hypoglycaemia
Tuesday, May 06, 2025Rezolute Inc a latestage company focused on rare diseases has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for its investigational treatment ersodetug
Datavant Expands Partnership with Boehringer Ingelheim to Strengthen Real-World Evidence Capabilities
Monday, May 05, 2025Datavant has extended its partnership with Boehringer Ingelheim to support the pharmaceutical companys growing focus on realworld evidence RWE The collaboration will see Datavants data connectivity
Illumina and Ovation.io launch unique GLP-1 dataset to support development of new therapies
Friday, May 02, 2025Illumina Inc and Ovationio Inc have jointly announced the creation of a largescale clinical multiomic dataset focused on patients treated with glucagonlike peptide GLP receptor agonist therapies
Curi Bio and Cook MyoSite Form Strategic Partnership to Advance Muscle and Metabolic Disease Research
Thursday, May 01, 2025Curi Bio a global provider of human D engineered tissue platforms has entered into a strategic partnership with Cook MyoSite a company specialising in skeletal musclebased therapies The collaboration aims to develop advanced human tissue
Er-Kim Signs Exclusive Agreement with Puma Biotechnology to Distribute NERLYNX® for Breast Cancer in Eastern Europe and Central Asia
Thursday, May 01, 2025ErKim a pharmaceutical company focused on introducing innovative therapies across the EMEA region has signed an exclusive distribution agreement with Puma Biotechnology Inc NASDAQ PBYI Under this agreement
Addex Signs Agreement with Sinntaxis for Exclusive Rights to mGlu5 Inhibitors in Brain Injury Recovery
Wednesday, April 30, 2025Addex Therapeutics a clinicalstage biopharmaceutical company listed on SIX and NASDAQ has entered into an option and collaboration agreement with Sinntaxis AB for exclusive rights to use intellectual property related to the treatment
